Earnings Report

搜索文档
Trane Technologies (TT) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-07-30 14:36
财务表现 - 公司2025年第二季度营收为57 5亿美元 同比增长8 3% [1] - 每股收益(EPS)为3 88美元 去年同期为3 30美元 [1] - 营收略低于Zacks共识预期57 6亿美元 差异-0 27% [1] - EPS超出共识预期3 76美元 实现+3 19%的正向差异 [1] 区域营收 - 美洲地区营收46 9亿美元 同比增长9 4% 低于分析师平均预期47 2亿美元 [4] - EMEA地区营收7 079亿美元 同比增长9 7% 超出分析师平均预期6 7748亿美元 [4] - 亚太地区营收3 462亿美元 同比下降6 7% 低于分析师平均预期3 5527亿美元 [4] 市场表现 - 过去一个月公司股价回报率+8 5% 同期标普500指数回报率为+3 4% [3] - 当前Zacks评级为3级(持有) 预示短期表现可能与大盘同步 [3] 运营指标 - 总订单金额56 3亿美元 略低于分析师平均预期的56 5亿美元 [4]
Entergy (ETR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-07-30 14:31
View all Key Company Metrics for Entergy here>>> Shares of Entergy have returned +6.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Operating Revenue- Natural Gas: $40.78 million versus the three-analyst average estimate of $34.61 million. The reported number represents a year-over-year change of +15.3%. Operating Revenue- Electric: $3.27 billion versus ...
Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-07-30 14:31
财务表现 - 2025年第二季度收入达7.986亿美元 同比增长11.7% [1] - 每股收益6.41美元 高于去年同期的5.85美元 [1] - 收入超市场共识预期7.9575亿美元 超出幅度0.36% [1] - 每股收益低于市场共识预期6.80美元 差距5.74% [1] 区域收入 - 美国市场收入7.598亿美元 较三位分析师平均预期7.4974亿美元高出1.4% [4] - 美国市场收入同比增长12.5% [4] - 国际市场收入3880万美元 较三位分析师平均预期3398万美元高出14.2% [4] - 国际市场收入同比下降2.3% [4] 产品线收入 - Tyvaso系列总收入4.696亿美元 同比增长17.9% [4] - Tyvaso美国市场收入4.553亿美元 接近两位分析师平均预期4.5261亿美元 [4] - Tyvaso DPI收入3.152亿美元 超五位分析师平均预期3.1348亿美元 [4] - 雾化Tyvaso收入1.544亿美元 基本符合五位分析师平均预期1.5453亿美元 [4] - Remodulin收入1.347亿美元 同比下降8.6% [4] - Orenitram收入1.239亿美元 同比增长15.7% [4] - Unituxin总收入5840万美元 同比增长13% [4] - Unituxin美国市场收入5540万美元 超两位分析师平均预期5307万美元 [4] - Adcirca收入650万美元 同比增长14% [4] - 其他产品收入550万美元 同比增长12.2% [4] 市场表现 - 过去一个月股价累计上涨2.3% [3] - 同期标普500指数上涨3.4% [3] - 当前Zacks评级为3级(持有) 预示近期表现可能与大盘同步 [3]
How Will Bristol Myers Squibb Stock React To Its Upcoming Earnings?
Forbes· 2025-07-30 14:15
CHONGQING, CHINA - JULY 29: In this photo illustration, a person holds a smartphone displaying the ... More logo of Bristol Myers Squibb Company (NYSE: BMY), a global biopharmaceutical firm focused on oncology, immunology, and cardiovascular diseases, with the company's purple hand-shaped branding visible in the background, on July 29, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images) Getty Images Bristol Myers Squibb (NYSE:BMY) is scheduled to release its earnings report on Thursday, ...
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
ZACKS· 2025-07-30 00:31
财务表现 - 公司报告季度收入为62186万美元,同比增长52% [1] - 每股收益(EPS)为154美元,高于去年同期的132美元 [1] - 收入超出Zacks共识预期60965万美元2% [1] - EPS超出共识预期139美元1079% [1] 业务细分 - 高敏锐度护理业务收入1070万美元,超出分析师平均预期1038万美元,同比增长92% [4] - 临终关怀业务收入215亿美元,超出分析师平均预期21075亿美元,同比增长54% [4] - 家庭健康业务收入3962亿美元,超出分析师平均预期38685亿美元,同比增长5% [4] 市场表现 - 公司股价过去一个月下跌15%,同期标普500指数上涨36% [3] - 目前Zacks评级为4级(卖出),预示短期内可能跑输大盘 [3] 分析视角 - 投资者通常通过比较收入、盈利与华尔街预期来决策 [2] - 关键业务指标更能准确反映公司财务健康状况 [2] - 对比历史数据和分析师预期有助于预测股价走势 [2]
Sensata (ST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-07-29 23:31
财务表现 - 公司第二季度营收为9 4338亿美元 同比下降89 [1] - 每股收益087美元 低于去年同期的093美元 [1] - 营收超分析师共识预期93326亿美元 达成109的惊喜 [1] - 每股收益超共识预期084美元 达成357的惊喜 [1] 业务分部表现 - 传感解决方案业务营收29116亿美元 超分析师预期27684亿美元 同比增长86 [4] - 性能传感业务营收65223亿美元 略低于分析师预期65662亿美元 同比下降99 [4] - 传感解决方案业务营业利润8804亿美元 超分析师预期8393亿美元 [4] - 性能传感业务营业利润14688亿美元 超分析师预期14484亿美元 [4] 市场反应 - 公司股价过去一个月上涨94 表现优于标普500指数36的涨幅 [3] - 公司目前获得Zacks买入评级 预示短期内可能跑赢大盘 [3] 关键指标重要性 - 除营收和盈利外 关键业务指标更能反映公司真实运营状况 [2] - 这些指标对整体财务表现有直接影响 有助于投资者更准确预测股价走势 [2]
Mondelez (MDLZ) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-07-29 23:01
Mondelez (MDLZ) reported $8.98 billion in revenue for the quarter ended June 2025, representing a year-over- year increase of 7.7%. EPS of $0.73 for the same period compares to $0.86 a year ago. Here is how Mondelez performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for Mondelez here>>> While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare t ...
Here's What Key Metrics Tell Us About Varonis (VRNS) Q2 Earnings
ZACKS· 2025-07-29 23:01
财务表现 - 2025年第二季度营收达1.5216亿美元 同比增长16.7% 超出市场预期2.96% [1] - 每股收益0.03美元 低于去年同期的0.05美元 但超出市场预期200% [1] - 年度经常性收入6.932亿美元 略高于分析师平均预估的6.8737亿美元 [4] 业务细分 - 维护与服务收入1389万美元 较分析师预估1768万美元低21.5% 同比大幅下降39.2% [4] - 定期许可订阅收入3237万美元 超出两家分析师平均预估2713万美元19.3% [4] - SaaS收入1.059亿美元 略高于两家分析师平均预估1.0503亿美元 [4] 市场表现 - 股价过去一个月回报率达7.2% 显著超越标普500指数3.6%的涨幅 [3] - 目前获Zacks评级第三级(持有)预示近期表现可能与大盘同步 [3] 分析框架 - 除营收和盈利外 关键绩效指标更能反映公司实际运营状况 [2] - 将指标与去年同期数据及分析师预估对比 可更准确预测股价走势 [2]
Compared to Estimates, Electronic Arts (EA) Q1 Earnings: A Look at Key Metrics
ZACKS· 2025-07-29 23:01
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Electronic Arts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: For the quarter ended June 2025, Electronic Arts (EA) reported revenue of $1.3 billion, up 2.9% over the same period last year. EPS came in at $0.25, compared to $ ...
NMI Holdings (NMIH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-07-29 23:01
NMI Holdings (NMIH) reported $173.78 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 7.2%. EPS of $1.22 for the same period compares to $1.20 a year ago. Shares of NMI Holdings have returned -10.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. The reported revenue represents a surprise of +1.87% over the Zack ...